HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.

AbstractOBJECTIVE:
To determine whether hormone replacement therapy (HRT) plus goserelin (Zoladex) is as effective as goserelin alone for the relief of pelvic symptoms of endometriosis and to determine whether it reduces both the loss of bone mineral density (BMD) and the physiologic side effects associated with goserelin therapy.
DESIGN:
Prospective, placebo-controlled study, open label for goserelin therapy and double-blind for HRT.
SETTING:
Forty-two teaching or community hospitals.
PATIENT(S):
Premenopausal women with symptomatic endometriosis.
RESULT(S):
Statistically significant mean decreases from baseline in the total pelvic symptom score and total subjective score were observed by week 24 for all three groups. There were no statistically significant treatment differences for change in total symptom score. Some degree of BMD loss occurred in the three groups; however, the percentage loss was consistently greater in the HRT0 group than in the HRT1 or HRT2 groups. When analyzed separately, no overall age effect on BMD change was seen in women >30 years of age versus women < or = 30 years. The HRT1 and HRT2 groups had fewer occurrences of hot flushes and vaginal dryness than did the HRT0 group.
CONCLUSION(S):
Goserelin plus HRT is as effective as goserelin alone in relieving pelvic symptoms of endometriosis and attenuates both the loss of BMD and the physiologic side effects of hot flushes and vaginal dryness associated with goserelin therapy.
AuthorsK S Moghissi, W D Schlaff, D L Olive, M A Skinner, H Yin
JournalFertility and sterility (Fertil Steril) Vol. 69 Issue 6 Pg. 1056-62 (Jun 1998) ISSN: 0015-0282 [Print] United States
PMID9627292 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Goserelin
Topics
  • Adolescent
  • Adult
  • Bone Density (drug effects)
  • Double-Blind Method
  • Endometriosis (physiopathology, therapy)
  • Estrogen Replacement Therapy
  • Female
  • Goserelin (adverse effects, therapeutic use)
  • Humans
  • Menstrual Cycle (physiology)
  • Middle Aged
  • Pelvis (physiopathology)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: